Cure8 research brief
Many people with IBD also have inflammatory joint disease. This combined clinic model aimed to provide simultaneous gastroenterology and rheumatology assessment and shared decision-making, and the study reports frequent coordinated treatment changes, better paired control over time, and high patient satisfaction.
Adults with IBD and coexisting inflammatory arthritis, gastroenterologists and rheumatologists interested in multidisciplinary care models, and clinic/service managers planning integrated services.
The study examined 78 patients attending 20 multidisciplinary clinics between 2021 and 2026; 73 had IBD (mostly Crohn’s) and 59 had inflammatory rheumatological diagnoses, mainly spondyloarthritis-spectrum disease.
The clinic commonly led to treatment changes: 36.6% of appointments involved advanced therapy changes and many switches/initiations were prompted by poor control of both IBD and rheumatologic disease.
The authors report that among 31 patients with paired follow-up assessments, the proportion with both gut and joint disease controlled rose from 19% to 58% (statistically significant), and surveyed patients reported very high satisfaction. The paper concludes the GRC model may improve coordinated care and warrants broader consideration.
The source is an abstracted clinical study from Frontline Gastroenterology reporting observational data from one combined clinic over five years. The sample for longitudinal paired assessments and the satisfaction survey was small, so results should be taken as preliminary operational evidence rather than definitive proof of effectiveness.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The review links specific therapies and surgical options to outcomes that matter to people with IBD — mucosal healing, lower hospitalizations, and reduced need for surgery — and highlights that combining medical and...
Understanding which patients are at higher risk for serious complications after IBD surgery can help patients and clinicians weigh risks, plan preoperative optimization, and guide research into preventive strategies.
Understanding how patient-derived epithelial cells respond to inflammation could reveal mechanisms of poor mucosal healing in IBD and identify targets or biomarkers to improve repair. Organoid models from patient tissue...
